Consent

This site uses third party services that need your consent.

Logo - FAIR4Rare Innovationfonds

FAIR4Rare

Contact
Susanne Vorhagen (Dr. rer. nat.) Project Coordinator/ Data Steward
Project Status
running
Kick-off Date
March 10, 2026

Description

There are more than 6,000 diseases, each of which is extremely rare. In total, however, several million people are affected in Germany alone. A disease is considered “rare” if it affects no more than five in 10,000 people. The National Register for Rare Diseases (NARSE) serves to record as many affected people as possible in the long term in order to determine the health effects and care structures of these diseases in Germany. It works according to the standardized and internationally used FAIR principles (Findable, Accessible, Interoperable, Reusable). The FAIR4Rare project is investigating the extent to which NARSE can close gaps in care. The focus is on cystic fibrosis, fragility diseases and genetic forms of obesity. The aim is to revise the minimum data set, i.e. the absolutely necessary information about a disease case, for the register. The aim of the work is to ensure that patient data can be found more reliably in the digital register and thus enable more patients to participate in progress in the diagnosis and treatment of rare diseases. The NARSE working methods are examined using the criteria of a SWOT analysis, i.e. strengths and weaknesses as well as opportunities and threats. To this end, NARSE users are surveyed and the registry data is compared with the datasets of the Medical Informatics Initiative of the Federal Ministry of Education and Research and the German Cystic Fibrosis Registry. Recommendations for the further development of NARSE within the existing structures will be derived from the analyses. The project will be funded for 30 months with a total of approx. 1.4 million euros. If successful, the results of the FAIR4Rare project can help the healthcare system make decisions to improve care for people with rare diseases.

Collaboration Partner

Logo - Universitätsklinikum Bonn
University Hospital Bonn
Learn More
Universitätsklinikum Tübingen
University Hospital Tübingen
Learn More
Logo - Uniklinikum Würzburg
University Hospital Würzburg
Learn More
Logo - Uniklinik RWTH Aachen
University Hospital Aachen
Learn More
Dresden University of Technology Learn More
University of Göttingen Learn More
Goethe University Frankfurt Learn More
Katholisches Klinikum Bochum Learn More

Achievements & Results

Es gibt mehr als 6.000 Erkrankungen, die jede für sich äußerst selten vorkommen. Insgesamt sind davon aber allein in Deutschland mehrere Millionen Menschen betroffen. Als „selten“ gilt eine Erkrankung, wenn sie nicht mehr als fünf von 10.000 Menschen betrifft. Das Nationale Register für Seltene Erkrankungen (NARSE) dient dazu, langfristig möglichst viele Betroffene zu erfassen, um so die gesundheitlichen Auswirkungen und die Versorgungsstrukturen dieser Erkrankungen in Deutschland zu ermitteln. Es arbeitet nach den standardisierten und international genutzten FAIR-Prinzipien (Findable, Accessible, Interoperable, Reusable – auf Deutsch: auffindbar, zugänglich, vergleichbar, wiederverwendbar).

Im Projekt FAIR4Rare wird geprüft, inwieweit das NARSE Versorgungslücken schließen kann. Der Fokus liegt dabei auf Mukoviszidose, Fragilitätserkrankungen und genetisch bedingten Adipositasformen. Dabei soll der Minimaldatensatz, also die unbedingt erforderlichen Informationen über einen Krankheitsfall, für das Register überarbeitet werden. Ziel der Arbeiten ist, dass die Patientendaten im digitalen Register zuverlässiger auffindbar sind und so mehr Betroffene am Fortschritt in Diagnostik und Therapie Seltener Erkrankungen teilhaben können.

Untersucht werden die NARSE-Arbeitsverfahren anhand der Kriterien einer SWOT‐Analyse, also Stärken (Strengths) und Schwächen (Weaknesses) sowie Möglichkeiten (Opportunities) und Gefährdungen (Threats). Dazu werden die Nutzerinnen und Nutzer des NARSE befragt und die Daten des Registers mit den Datenbeständen der Medizininformatik‐Initiative des Bundesministeriums für Bildung und Forschung und dem Deutschen Mukoviszidose Register verglichen. Aus den Analysen werden Handlungsempfehlungen für die Weiterentwicklung des NARSE im Rahmen der bestehenden Strukturen abgeleitet. Das Projekt wird für 30 Monate mit insgesamt ca. 1,4 Millionen Euro gefördert.

Im Erfolgsfall können die Ergebnisse des FAIR4Rare-Projekts helfen, im Gesundheitssystem Entscheidungen zur Verbesserung der Versorgung von Menschen mit Seltenen Erkrankungen zu treffen.

Publications

Linking international registries to FHIR and Phenopackets with RareLink: a scalable REDCap-based framework for rare disease data interoperability

2025 - Open Access -
Adam S.L. Graefe, Filip Rehburg, Samer Alkarkoukly, Daniel Danis, Ana Grönke, Miriam R. Hübner, Alexander Bartschke, Thomas Debertshäuser, Sophie A.I. Klopfenstein, Julian Saß, Julia Fleck, Mirko Rehberg, Jana Zschüntzsch, Elisabeth F. Nyoungui, Tatiana Kalashnikova, Luis Murguía-Favela, Beata Derfalvi, Nicola A.M. Wright, Shahida Moosa, Soichi Ogishima, Oliver Semler, Susanna Wiegand, Peter Kuehnen, Christopher J. Mungall, Melissa A. Haendel, Peter N. Robinson, Sylvia Thun, Oya Beyan

While Research Electronic Data Capture (REDCap) has been widely adopted in rare disease research, its unconstrained data format often leads to implementations that lack native interoperability with global health data standards, limiting secondary data use. To address this, we developed and validated RareLink, an open-source framework implementing our previously-published ontology-based rare disease common data model, enabling standardised data exchange between REDCap, international registries, and downstream analysis tools. Its preconfigured pipelines interact with the local REDCap application programming interface and enable semi-automatic import or export of data to the Global Alliance for Genomics and Health (GA4GH) Phenopackets and Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) instances, conforming to the HL7 International Patient Summary and Genomics Reporting profiles. The framework was developed in three iterative phases using retrospective and prospective clinical data from patients with various rare metabolic and neuromuscular disorders, as well as inborn errors of immunity. Phase one involved deployment across four German university hospitals for registry and data analysis purposes. Phase two integrated RareLink with the Canadian Inborn Errors of Immunity National Registry, enhancing extensibility. Phase three focuses on international implementation in South Africa and Japan to assess global scalability. Implementation feedback was continuously incorporated to validate outputs and improve usability. For evaluation purposes, we defined a simulated Kabuki syndrome cohort based on published cases and demonstrated data export to both Phenopackets and FHIR instances. RareLink can enhance the clinical utility of REDCap by enabling structured data analysis and interoperability. Its global applicability and open-source nature can support equitable rare disease research with the ultimate goal to improve patient care. Broader adoption and coordination with entities such as HL7 and the European Reference Networks are thus essential to realise its full potential. The framework and its documentation are freely available through GitHub and Read the Docs, respectively

An ontology-based rare disease common data model harmonising international registries, FHIR, and Phenopackets

2025 - Open Access -
Adam S. L. Graefe, Miriam R. Hübner, Filip Rehburg, Steffen Sander, Sophie A. I. Klopfenstein, Samer Alkarkoukly, Ana Grönke, Annic Weyersberg, Daniel Danis, Jana Zschüntzsch, Elisabeth F. Nyoungui, Susanna Wiegand, Peter Kühnen, Peter N. Robinson, Oya Beyan & Sylvia Thun

Although rare diseases (RDs) affect over 260 million individuals worldwide, low data quality and scarcity challenge effective care and research. This work aims to harmonise the Common Data Set by European Rare Disease Registry Infrastructure, Health Level 7 Fast Healthcare Interoperability Base Resources, and the Global Alliance for Genomics and Health Phenopacket Schema into a novel rare disease common data model (RD-CDM), laying the foundation for developing international RD-CDMs aligned with these data standards. We developed a modular-based GitHub repository and documentation to account for flexibility, extensions and further development. Recommendations on the model’s cardinalities are given, inviting further refinement and international collaboration. An ontology-based approach was selected to find a common denominator between the semantic and syntactic data standards. Our RD-CDM version 2.0.0 comprises 78 data elements, extending the ERDRI-CDS by 62 elements with previous versions implemented in four German university hospitals capturing real world data for development and evaluation. We identified three categories for evaluation: Medical Data Granularity, Clinical Reasoning and Medical Relevance, and Interoperability and Harmonisation.